3 results about "Cerebral arteriosclerosis" patented technology

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine formula for treating primary hypertension. The traditional Chinese medicine formula for treating primary hypertension comprises the following components in parts by weight: 10-15 parts of angelica sinensis; 10 to 15 parts of radix rehmanniae; 5-10 parts of Chinese herbaceous peony; 15 to 20 parts of radix puerariae; 5 to 10 parts of fructus gardeniae; 3-7 parts of coptis chinensis; 5-10 parts of radix scutellariae; 10 to 15 parts of hawthorn; 10-15 parts of eucommia ulmoides; 3-6 parts of fritillary bulb; 2-6 parts of radix aucklandiae; 4-9 parts of polygala tenuifolia; 1-4 parts of rhizoma cyperi; 3-7 parts of earthworm; 5-10 parts of radix astragali; 5-10 parts of motherwort herb; 1-2 parts of herba siegesbeckiae; and 1-2 parts of apocynum venetum. The traditional Chinese medicine formula for treating primary hypertension provided by the invention has the effects of treating primary hypertension, Meniere's syndrome, cerebral arteriosclerosis, vertebrobasilar artery insufficiency, nervous tinnitus and neurasthenia; the traditional Chinese medicine composition is remarkable in antihypertensive effect, safe and free of side effects.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and discloses a TCM composition, preparation method, and oral formulation for treating cardiovascular and cerebrovascular diseases of the Qi deficiency and blood stasis type. The TCM composition is made from kudzu root, astragalus root, notoginseng, safflower, chuanxiong rhizome, hawthorn, angelica root, polygonum cuspidatum, licorice root, and salvia miltiorrhiza in specific weight parts. A preferred ratio is 60 parts kudzu root, 60 parts astragalus root, 25 parts notoginseng, 30 parts safflower, 25 parts chuanxiong rhizome, 30 parts hawthorn, 25 parts angelica root, 25 parts polygonum cuspidatum, 10 parts licorice root, and 26 parts salvia miltiorrhiza. It can be used for coronary heart disease, cerebral arteriosclerosis, cerebral thrombosis, hyperlipidemia, or sequelae of cerebral infarction. In preparation, the medicinal materials are cleaned, dried, mixed, and pulverized into a fine powder, passed through a 120-180 mesh sieve, and then formed into water pills using water as a binder. After drying and packaging, the product is obtained. This invention has a scientific formulation and precise proportions, making it suitable for the long-term prevention and treatment of cardiovascular and cerebrovascular diseases of the Qi deficiency and blood stasis type.

The present invention provides a pharmaceutical composition containing ticagrelor for use in reducing or preventing thromboembolic events before and / or during and / or after neurovascular arterial procedures in a patient requiring the use of the pharmaceutical composition containing ticagrelor, comprising administering an effective amount of the pharmaceutical composition containing ticagrelor to a patient, wherein the pharmaceutical composition is an aqueous solution containing a solubilizing agent for ticagrelor and the pharmaceutical composition is administered intravenously; wherein the patient suffers from a cerebral aneurysm, cerebral arteriosclerosis, cervical arteriosclerosis, neurovascular carotid dissection or carotid dissection.